Abbott Laboratories (FRA:ABL) Accounts Payable & Accrued Expense : €11,050 Mil (As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Abbott Laboratories Accounts Payable & Accrued Expense?

Abbott Laboratories's quarterly accounts payable & accrued expense increased from Sep. 2023 (€11,236 Mil) to Dec. 2023 (€11,702 Mil) but then declined from Dec. 2023 (€11,702 Mil) to Mar. 2024 (€11,050 Mil).

Abbott Laboratories's annual accounts payable & accrued expense increased from Dec. 2021 (€10,931 Mil) to Dec. 2022 (€12,497 Mil) but then declined from Dec. 2022 (€12,497 Mil) to Dec. 2023 (€11,702 Mil).

Abbott Laboratories Accounts Payable & Accrued Expense Historical Data

The historical data trend for Abbott Laboratories's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Accounts Payable & Accrued Expense Chart

Abbott Laboratories Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

8,446.50

9,606.71

10,930.64

12,496.67

11,701.84

Abbott Laboratories Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															11,436.83	11,136.92	11,235.57	11,701.84	11,050.12

Abbott Laboratories Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Abbott Laboratories (FRA:ABL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (FRA:ABL) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

ABT:USA ABT:Mexico 0Q15:UK ABL:Germany ABT:Chile ABT:Switzerland ABTT34:Brazil ABT:Austria ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.